Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jayant S. Goda"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Tumors of the Central nervous System (CNS) are a spectrum of neoplasms that range from benign lesions to highly malignant and aggressive lesions. Despite aggressive multimodal treatment approaches, the morbidity and mortality are high with dismal sur
Externí odkaz:
https://doaj.org/article/3c2ea8aaf54945dfa0a5da8f2753b171
Autor:
Sweety Asija, Abhishek Chatterjee, Jayant S. Goda, Sandhya Yadav, Godhanjali Chekuri, Rahul Purwar
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Glioblastoma is one of the most difficult tumor types to manage, having high morbidity and mortality with available therapies (surgery, radiotherapy and chemotherapy). Immunotherapeutic agents like Oncolytic Viruses (OVs), Immune Checkpoint Inhibitor
Externí odkaz:
https://doaj.org/article/54a77fe295b74b7db7042e7f6852d5d1
Autor:
Amrita Guha, Jayant S. Goda, Archya Dasgupta, Abhishek Mahajan, Soutik Halder, Jeetendra Gawde, Sanjay Talole
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGlioblastoma (GBM) and primary central nervous system lymphoma (PCNSL) are common in elderly yet difficult to differentiate on MRI. Their management and prognosis are quite different. Recent surge of interest in predictive analytics, using
Externí odkaz:
https://doaj.org/article/42721140365c47f4984e2c3e0b45b98b
Autor:
Pashmina Kandalgaonkar, Arpita Sahu, Ann Christy Saju, Akanksha Joshi, Abhishek Mahajan, Meenakshi Thakur, Ayushi Sahay, Sridhar Epari, Shwetabh Sinha, Archya Dasgupta, Abhishek Chatterjee, Prakash Shetty, Aliasgar Moiyadi, Jaiprakash Agarwal, Tejpal Gupta, Jayant S. Goda
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and purposeSemantic imaging features have been used for molecular subclassification of high-grade gliomas. Radiomics-based prediction of molecular subgroups has the potential to strategize and individualize therapy. Using MRI texture featu
Externí odkaz:
https://doaj.org/article/348df603c7c144b0987d167a8c8eca6c
Autor:
Sweety, Asija, Abhishek, Chatterjee, Sandhya, Yadav, Godhanjali, Chekuri, Atharva, Karulkar, Ankesh Kumar, Jaiswal, Jayant S, Goda, Rahul, Purwar
Publikováno v:
International Reviews of Immunology. 41:582-605
The aggressive and recurrent nature of glioblastoma is multifactorial and has been attributed to its biological heterogeneity, dysfunctional metabolic signaling pathways, rigid blood-brain barrier, inherent resistance to standard therapy due to the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ab1899878e55aaf950a7227194da95
https://doi.org/10.1080/08830185.2022.2101647
https://doi.org/10.1080/08830185.2022.2101647
Autor:
Goutam Panda, Babusha Kalra, Anupam Rishi, Nehal Khanna, Sangeeta Kakoti, Epari Sridhar, Tanuja Shet, Manju Sengar, Lingaraj Nayak, Bahusaheb Bagal, Hasmukh Jain, Siddartha S Laskar, Jayant S. Goda
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:513-522
Orbital mucosa-associated lymphoid tissue (MALT) lymphoma, which are rare and indolent, often present at an early stage. We report the efficacy and safety outcomes of treatment in these patients.We analyzed adult patients with stage IE or IIE orbital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::522ce8e86b28054e4d645b824f2f607f
https://doi.org/10.1016/j.clml.2021.12.013
https://doi.org/10.1016/j.clml.2021.12.013
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 342-343 (2020)
Externí odkaz:
https://doaj.org/article/f21918e6b5364f9e803bbb6de6dab9db
Autor:
Puja Sandbhor, Jayant. S. Goda, Bhabani Mohanty, Pradip Chaudhari, Shilpee Dutt, Rinti Banerjee
Publikováno v:
Nanoscale. 14:12773-12788
Spatiotemporal targeting of anti-glioma drugs remains a pressing issue in glioblastoma (GBM) treatment. We challenge this issue by developing a minimally invasive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3675f9f83f6fe09856f9dd1d7fd86996
https://doi.org/10.1039/d2nr00171c
https://doi.org/10.1039/d2nr00171c
Autor:
Vijay M Patil, Nikhil Pande, Arun Chandrasekharan, Chandrakanth M, Raees Tonse, Rahul Krishnatry, Jayant S Goda, Hollis Dsouza, Dilip Harindran Vallathol, Santam Chakraborty, Tejpal Gupta, Rakesh Jalali
Publikováno v:
CNS Oncology, Vol 7, Iss 2 (2018)
Aim: This study was designed with a primary objective to study the rate of agreement in treatment plan and decisions between video follow-up (VF) and conventional clinic follow-up (CF). Patients & methods: Adult patients with intermediate- to high-gr
Externí odkaz:
https://doaj.org/article/f57064bf4a35484b96b30f311d3c6e23
Autor:
Jayant S. Goda
supplementary document for Journal of Personalised Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1a5b54d56a4646508888db4fef136c
